title: Saxagliptin and Heart Failure in the SAVOR-TIMI 53 Trial: Reflections on the Bradford Hill Criteria.
authors.affiliation: Centro de Salud San Antón, Cartagena, Murcia, Spain.
authors.forename: Ana M
authors.initials: AM
authors.lastname: Cebrián Cuenca
authors.affiliation: Centro de Salud Cabo Huertas, San Juan de Alicante, Alicante, Spain.
authors.forename: Domingo
authors.initials: D
authors.lastname: Orozco Beltrán
authors.affiliation: Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain.
authors.forename: Jorge
authors.initials: J
authors.lastname: Navarro Pérez
authors.affiliation: Centro de Salud de la Ribera del Órbigo, Benavides de Órbigo, León, Spain.
authors.forename: Fernando
authors.initials: F
authors.lastname: Álvarez-Guisasola
authors.affiliation: Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain.
authors.forename: Julio
authors.initials: J
authors.lastname: Núñez Villota
authors.affiliation: Servicio de Cardiología, Hospital General Universitario de Santa Lucía, Cartagena, Murcia, Spain. Electronic address: lconsue@gmail.com.
authors.forename: Luciano
authors.initials: L
authors.lastname: Consuegra-Sánchez
mesh_terms: D000218:Adamantane / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015984:Causality; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004151:Dipeptides / Q000627:therapeutic use*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D006333:Heart Failure; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D016016:Proportional Hazards Models
chemical_list: D004151:Dipeptides; D054873:Dipeptidyl-Peptidase IV Inhibitors; C502994:saxagliptin; D000218:Adamantane